Psyched Wellness Provides Corporate Update
Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Announces Appointment of New Director and Resignation of a Director
Psyched Wellness Announces Supply Chain Disruption in the US
Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer
Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA
Psyched Wellness Announces Grant of Options
Psyched Wellness Closes Final US$2.5M Tranche of Its Non-Brokered Private Placement for a Total of US$7.5M with Gotham Green Partners and Provides Corporate Update
Psyched Wellness and Gotham Green Partners to Close Final Tranche of US$2.5M for a Total of US$7.5M Raised and Partner with Strategic Advisors to Build Consumer Packaged Goods Derived from AME-1
Psyched Wellness Provides Corporate Update
Psyched Wellness Provides Update on Non-Brokered Private Placement
Psyched Wellness's Calm, First Legal Amanita Muscaria Extract, Arrives at Pop-up Grocer in NYC
Psyched Wellness Is Pleased To Announce Sponsorship and Activation at The Wonderland Conference in Miami on Nov 9 - 11
Psyched Wellness Lists Calm at All Market of Choice Locations in the United States
Psyched Wellness Lists Calm at All Central Market Locations in the United States
Psyched Wellness Lists Calm at All Erewhon Market Locations in the United States
As Previously Disclosed on September 1, 2023, Psyched Wellness Closes Tranche 2A of Non-Brokered Private Placement, Amends and Restates Investor Rights Agreement, Provides Corporate Update and Announces Director Change
Psyched Wellness Closes Tranche 2A of Non-Brokered Private Placement, Amends and Restates Investor Rights Agreement, Provides Corporate Update and Announces Director Change
Psyched Wellness Is Pleased To Announce Partnership with National Sales and Distribution Organization, POD Foods
Psyched Wellness Is Excited To Announce The Launch of Amanita Gummies with My Crew Doses Inc., a Natural Formulation House and Brand
Psyched Wellness Is Excited to Announce That Calm Continues eCommerce Expansion, Listing with the World's Largest Retailer
Psyched Wellness Is Excited to Announce That Calm Has Been Listed on the World's Largest E-Commerce Marketplace, Amazon.com
Psyched Wellness Is Pleased to Announce That Calm Has Shipped to National Sales and Distribution Partner TruLife Distribution
Psyched Wellness Is Pleased to Announce That Calm Will Be Marketed at the ECRM Conference and the Natural Products Expo West Through Its New Distribution Partnerships
Psyched Wellness launches affiliate program for its Amanita Muscaria-derived extract Calm
Psyched Wellness announces sales partnership with Spacestation CPG for its proprietary Amanita Muscaria mushroom product Calm
Psyched Wellness announces launch of e-commerce fulfillment with ShipHero8
Psyched Wellness announces purchase agreement with Choice Companies for its Amanita Muscaria mushroom tincture Calm
Psyched Wellness delivers preorders of its flagship product Calm and reopens online store
Psyched Wellness strengthens IP portfolio with update and provisional patent filing
Psyched Wellness announces successful pilot run of Amanita Muscaria extract product Calm
Psyched Wellness inks key supply agreements ahead of anticipated launch of its first Amanita Muscaria mushroom-derived product Calm
Psyched Wellness enters eCommerce fulfillment partnership with ShipHero for its Amanita Muscaria mushroom extract Calm
Psyched Wellness reveals new preliminary data highlighting important functional properties of AME-1 extract
Psyched Wellness announces that its proprietary Amanita Muscaria Extract (AME-1) is now available for preorder in the USA
Psyched Wellness gearing up for launch of Amanita Muscaria-derived product Calm in the US later this year
Psyched Wellness says pilot production of its Amanita Muscaria product ‘Calm' to start on July 7, 2022
Psyched Wellness Announces Date for Their Pilot Production Run of the First Legal Amanita Muscaria Tincture Product, Calm
Psyched Wellness announces launch of first online store
Psyched Wellness says it received C$226,500 from sale of non-core assets
Psyched Wellness hires marketing and communications professional Del Mahabadi
Psyched Wellness announces key findings from 90-day oral toxicity study on Amanita Muscaria extract
Psyched Wellness to Participate in Upcoming Investor Conferences in April 2022